These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9236953)

  • 21. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the utility of everyday memory test and the Alzheimer's Disease Assessment Scale-Cognitive part for evaluation of mild cognitive impairment and very mild Alzheimer's disease.
    Adachi H; Shinagawa S; Komori K; Toyota Y; Mori T; Matsumoto T; Sonobe N; Kashibayashi T; Ishikawa T; Fukuhara R; Ikeda M
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):148-53. PubMed ID: 23581865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
    Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
    Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach.
    Tractenberg RE; Weiner MF; Cummings JL; Patterson MB; Thal LJ
    J Neuropsychiatry Clin Neurosci; 2005; 17(1):51-60. PubMed ID: 15746483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.
    Lacey L; Bobula J; Rüdell K; Alvir J; Leibman C
    Value Health; 2015 Jul; 18(5):638-45. PubMed ID: 26297092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
    Suh GH; Ju YS; Yeon BK; Shah A
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer's disease.
    Costa AS; Reich A; Fimm B; Ketteler ST; Schulz JB; Reetz K
    Dement Geriatr Cogn Disord; 2014; 37(1-2):95-103. PubMed ID: 24107412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of patient dependence in mild-to-moderate Alzheimer's disease.
    Benke T; Sanin G; Lechner A; Dal-Bianco P; Ransmayr G; Uranüs M; Marksteiner J; Gaudig M; Schmidt R;
    J Alzheimers Dis; 2015; 43(2):443-9. PubMed ID: 25096619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neurologic syndrome of severe Alzheimer's disease. Relationship to functional decline.
    Franssen EH; Kluger A; Torossian CL; Reisberg B
    Arch Neurol; 1993 Oct; 50(10):1029-39. PubMed ID: 8215960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical progression of moderate-to-severe Alzheimer's disease and caregiver burden: a 12-month multicenter prospective observational study.
    Agüera-Ortiz L; Frank-García A; Gil P; Moreno A;
    Int Psychogeriatr; 2010 Dec; 22(8):1265-79. PubMed ID: 20849672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The validity and reliability of the Spanish version of the Severe Cognitive Impairment Profile (SCIP) for the cognitive assessment of persons with advanced stages of Alzheimer's disease].
    Buiza C; Montorio-Cerrato I; Yanguas J
    Rev Neurol; 2015 Oct; 61(8):349-56. PubMed ID: 26461128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Korean version of the Baylor Profound Mental Status Examination: a brief staging measure for patients with severe Alzheimer's disease.
    Na HR; Lee SH; Lee JS; Doody RS; Kim SY
    Dement Geriatr Cogn Disord; 2009; 27(1):69-75. PubMed ID: 19145080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease.
    Spalletta G; Baldinetti F; Buccione I; Fadda L; Perri R; Scalmana S; Serra L; Caltagirone C
    J Neurol; 2004 Jun; 251(6):688-95. PubMed ID: 15311344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a straightforward and sensitive scale for MCI and early AD clinical trials.
    Huang Y; Ito K; Billing CB; Anziano RJ;
    Alzheimers Dement; 2015 Apr; 11(4):404-14. PubMed ID: 25022537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale--cognitive subscale].
    Pákáski M; Drótos G; Janka Z; Kálmán J
    Orv Hetil; 2012 Mar; 153(12):461-6. PubMed ID: 22411219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability and validity of the severe impairment battery in Taiwanese patients with moderate to severe Alzheimer's disease.
    Huang MH; Tsai CF; Hu CJ; Lin YT; Yang YH; Wang WF; Lee WJ; Fuh JL
    J Chin Med Assoc; 2020 Nov; 83(11):1014-1019. PubMed ID: 32796320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease.
    Morris JC; Edland S; Clark C; Galasko D; Koss E; Mohs R; van Belle G; Fillenbaum G; Heyman A
    Neurology; 1993 Dec; 43(12):2457-65. PubMed ID: 8255439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.